HSP70/HSF1 axis, regulated <i>via</i> a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemiaFederica Frezzato(University of Padua), Livio Trentin(University of Padua)International Journal of CancerMay 2, 201910.1002/ijc.32383Cited by 40SaveCiteExport RISWatch citationsRelated PapersGeldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia|Blood|2008|55HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen|PLoS ONE|2012|32